Hims & Hers Health, Inc. (HIMS) vs Insulet Corp. (PODD)
A side-by-side comparison of Hims & Hers Health, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.
HIMS
Hims & Hers Health, Inc.
$33.78HealthcareAt close: Aug 21, 2026, 4:00 PM ET
PODD
Insulet Corp.
$148.16HealthcareAt close: Aug 21, 2026, 4:00 PM ET
Total return — HIMS vs PODD
growth of $100 · dividends reinvested · last 7yHIMS +244.7% (+19.3%/yr)PODD +3.4% (+0.5%/yr)HIMS compounded faster over this window
HIMS PODD
HIMS vs PODD: by the numbers
- •PODD is the larger company ($10.26B vs $7.54B market cap).
- •PODD is profitable (12.29% net margin) while HIMS runs a net loss (-5.51%).
- •HIMS grew revenue faster over the past five years (67.47% vs 25.13% CAGR).
Metrics side by side
Valuation
| Metric | HIMS | PODD |
|---|---|---|
| P/E ratio | N/A | 27.69 |
| Forward P/E | N/A | 22.78 |
| P/S ratio | 3.04 | 3.37 |
| P/B ratio | 24.16 | 7.23 |
| EV / EBITDA | 81.70 | 17.22 |
| FCF yield | 1.15% | 2.90% |
Profitability
| Metric | HIMS | PODD |
|---|---|---|
| Gross margin | 73.84% | 71.08% |
| Operating margin | 4.50% | 16.89% |
| Net margin | -5.51% | 12.29% |
| ROE | -43.83% | 26.39% |
| ROIC | -4.30% | 16.04% |
Growth (annualized)
| Metric | HIMS | PODD |
|---|---|---|
| Revenue CAGR (5Y) | 67.47% | 25.13% |
| EPS CAGR (5Y) | N/A | 99.91% |
| Total return CAGR (5Y) | 36.55% | -12.88% |
Frequently asked
- Which has grown faster, HIMS or PODD?
- Over the past five years, HIMS grew revenue faster — HIMS at a 67.47% CAGR versus PODD at 25.13%.
- Is HIMS or PODD more profitable?
- PODD runs the higher net margin — HIMS at -5.51% versus PODD at 12.29%.
- How have HIMS and PODD total returns compared?
- Over the past 5 years, HIMS delivered 36.55% and PODD delivered 13.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Insulet P/E ratioHims & Hers Health ROEInsulet ROEHims & Hers Health operating marginInsulet operating marginHims & Hers Health revenue growthInsulet revenue growthHims & Hers Health free cash flowInsulet free cash flow
Hims & Hers Health & Insulet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.